Milestone® Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Milestone Pharmaceuticals (Nasdaq: MIST) announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference in New York City from September 9-11, 2024. President and CEO Joe Oliveto will engage in a Fireside Chat on September 10th at 2 PM EDT.
The event will be accessible via webcast, available both live and as a replay for approximately 90 days after the presentation. Interested parties can view the webcast in the News & Events section of Milestone's website at www.milestonepharma.com.
This participation provides an opportunity for Milestone Pharmaceuticals to showcase its latest developments and engage with investors in a prominent global investment forum.
Milestone Pharmaceuticals (Nasdaq: MIST) ha annunciato la sua partecipazione alla 26ª Conferenza Annuale di Investimenti Globali H.C. Wainwright a New York dal 9 all'11 settembre 2024. Il presidente e CEO Joe Oliveto parteciperà a una conversazione informale il 10 settembre alle 14:00 EDT.
L'evento sarà accessibile tramite webcast, disponibile sia in diretta che come registrazione per circa 90 giorni dopo la presentazione. Le parti interessate possono visualizzare il webcast nella sezione News & Events del sito web di Milestone all'indirizzo www.milestonepharma.com.
Questa partecipazione offre a Milestone Pharmaceuticals l'opportunità di mostrare i suoi ultimi sviluppi e di interagire con gli investitori in un importante forum di investimento globale.
Milestone Pharmaceuticals (Nasdaq: MIST) anunció su participación en la 26ª Conferencia Anual de Inversión Global de H.C. Wainwright en la ciudad de Nueva York del 9 al 11 de septiembre de 2024. El presidente y CEO Joe Oliveto participará en una charla informal el 10 de septiembre a las 2 PM EDT.
El evento será accesible a través de un webcast, disponible tanto en vivo como en repetición durante aproximadamente 90 días después de la presentación. Las partes interesadas pueden ver el webcast en la sección de Noticias y Eventos del sitio web de Milestone en www.milestonepharma.com.
Esta participación brinda a Milestone Pharmaceuticals la oportunidad de mostrar sus últimos desarrollos e interactuar con inversores en un destacado foro de inversión global.
Milestone Pharmaceuticals (Nasdaq: MIST)는 2024년 9월 9일부터 11일 사이 뉴욕에서 열리는 H.C. Wainwright 제26회 연례 글로벌 투자 회의에 참여할 것이라고 발표했습니다. CEO인 Joe Oliveto는 9월 10일 오후 2시 EDT에 파이어사이드 채팅에 참가할 예정입니다.
이번 행사는 웹캐스트를 통해 실시간 및 프레젠테이션 후 약 90일간 다시 볼 수 있습니다. 관심 있는 분들은 Milestone의 웹사이트 www.milestonepharma.com의 뉴스 및 이벤트 섹션에서 웹캐스트를 시청할 수 있습니다.
이번 참여는 Milestone Pharmaceuticals가 최근 개발 내용을 선보이고 글로벌 투자 포럼에서 투자자와 소통할 수 있는 기회를 제공합니다.
Milestone Pharmaceuticals (Nasdaq: MIST) a annoncé sa participation à la 26ème Conférence Annuelle d'Investissement Mondial H.C. Wainwright à New York du 9 au 11 septembre 2024. Le président et PDG Joe Oliveto participera à une discussion informelle le 10 septembre à 14h EDT.
L'événement sera accessible via un webinaire, disponible en direct et en rediffusion pendant environ 90 jours après la présentation. Les personnes intéressées peuvent visionner le webinaire dans la section Actualités et Événements du site de Milestone à www.milestonepharma.com.
Cette participation offre à Milestone Pharmaceuticals l'opportunité de présenter ses derniers développements et d'interagir avec les investisseurs dans un forum d'investissement mondial de premier plan.
Milestone Pharmaceuticals (Nasdaq: MIST) gab seine Teilnahme an der 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright in New York City vom 9. bis 11. September 2024 bekannt. Präsident und CEO Joe Oliveto wird am 10. September um 14 Uhr EDT an einem Fireside Chat teilnehmen.
Die Veranstaltung wird über Webcast zugänglich sein, sowohl live als auch als Wiederholung für etwa 90 Tage nach der Präsentation. Interessierte Parteien können den Webcast im Bereich Nachrichten und Veranstaltungen auf der Website von Milestone unter www.milestonepharma.com ansehen.
Die Teilnahme bietet Milestone Pharmaceuticals die Möglichkeit, seine neuesten Entwicklungen zu präsentieren und mit Investoren in einem wichtigen globalen Investitionsforum in Kontakt zu treten.
- None.
- None.
MONTREAL and CHARLOTTE, N.C., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that President and CEO, Joe Oliveto, will participate in the H.C. Wainwright 26th Annual Global Investment Conference, to take place from September 9-11, 2024, in New York City.
The Fireside Chat will be on September 10th at 2 PM EDT. The webcast is available to watch both live and replay for approximately 90 days following the presentation in the News & Events section of Milestone's website www.milestonepharma.com.
About Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a biopharmaceutical company developing and commercializing innovative cardiovascular solutions to improve the lives of people living with complex and life-altering heart conditions. The Company’s focus on understanding unmet patient needs and improving the patient experience has led us to develop new treatment approaches that provide patients with an active role in self-managing their care. Milestone’s lead investigational product is etripamil, a novel calcium channel blocker nasal spray that is being studied for patients to self-administer without medical supervision to treat symptomatic episodic attacks associated with PSVT and AFib-RVR.
Contact:
Kim Fox, Vice President, Communications,
kfox@milestonepharma.com
Investor Relations
Chris Calabrese,
ccalabrese@lifesciadvisors.com
Kevin Gardner,
kgardner@lifesciadvisors.com
FAQ
When is Milestone Pharmaceuticals (MIST) presenting at the H.C. Wainwright Global Investment Conference?
Who will represent Milestone Pharmaceuticals (MIST) at the H.C. Wainwright conference?
How can investors watch Milestone Pharmaceuticals' (MIST) presentation at the H.C. Wainwright conference?
What are the dates for the H.C. Wainwright Global Investment Conference featuring Milestone Pharmaceuticals (MIST)?
